Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 41 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Phase II Results of the Porcupine (PORCN) Inhibitor Zamaporvint (RXC004) in Patients with Pancreatic and Biliary Tract Cancer
J. A. Bridgewater,L. Chantrill,R. Gillmore,R. Hubner,N. Starling, F. Froeling,H. S. Wasan,B. Basu, F. Collison,B. Markman,M. Chisamore, L. Goodwin, D. Wilson, C. Phillips, J. Robertson, H. Timmis, Z. Setchellova, S. A. Woodcock,J. W. Valle
ANNALS OF ONCOLOGY (2024): S157-S157
Cited0Views0Bibtex
0
0
391P Phase II Results of the Porcupine (PORCN) Inhibitor Zamaporvint (RXC004) in Patients with Pancreatic and Biliary Tract Cancer
J.A. Bridgewater,L. Chantrill,R. Gillmore,R. Hubner,N. Starling, F. Froeling,H.S. Wasan,B. Basu, F. Collison,B. Markman,M. Chisamore, L. Goodwin, D. Wilson, C. Phillips, J. Robertson, H. Timmis, Z. Setchellova, S.A. Woodcock,J.W. Valle
Annals of Oncology (2024): S157
Cited0Views0Bibtex
0
0
OA08.07 Sacituzumab Govitecan + Pembrolizumab + Carboplatin in 1L Metastatic Non-Small Cell Lung Cancer: the EVOKE-02 Study
J. Gray, J. Neal, J.D. Patel, S.V. Liu, N. Girard,M. Reck,F. Cappuzzo,M. Cobo Dols, N. Reguart,J. Fuentes Pradera,B.C. Cho, M. Li,S. Mekan,F. Safavi,N. Fernando, D. Karumanchi,M. Chisamore,E.B. Garon
Journal of Thoracic Oncologyno. 10 (2024): S27
Cited0Views0Bibtex
0
0
1084P Phase II Study of AI-designed Personalized Neoantigen Cancer Vaccine, EVX-01, in Combination with Pembrolizumab in Advanced Melanoma
M.A.A. Khattak, P.A. Ascierto, P. Queirolo,M. Chisamore, D. Kleine-Kohlbrecher, M. Lausen, N. Viborg, M.A. Pavlidis, R.O. Andersen, T.S. Jepsen, S.F. Thorsen, T. Trolle, B. Rønø, G.V. Long
Annals of Oncology (2024): S718-S719
Cited0Views0Bibtex
0
0
LBA32 A Randomized, Phase II, Dose Optimization of Gotistobart, a Ph-Sensitive Anti-Ctla-4, in Combination with Standard Dose Pembrolizumab in Platinum-Resistant Recurrent Ovarian Cancer: Safety, Efficacy and Dose Optimization (PRESERVE-004/GOG-3081)
J.N. Barlin, P.C. Lim, J. Thomes Pepin, E.E. Hopp,N.G. Cloven, C. Lee, H.D. Eshed, D. Black, H.M. Cottrill, L. Hand, D.M. O'Malley,L.T. Chuang,L. Willmott,M. Chisamore, S. Shpyro, J. Durbin, P. Zheng, Y. Liu, B.J. Monk
Annals of Oncology (2024): S1224-S1225
Cited0Views0Bibtex
0
0
758P Results of the Phase Ib Study of NC410 Combined with Pembrolizumab in Ovarian Cancer Patients
E. Zsiros, E.S. Christenson,D. Sohal,S. Manda, S. Fu, A. Martz, M. Zika, S. Kordahi, P. Kothari, S. Kahan, E.A. Barbu, A. Morawski,D. Flies, S.A.R. Langermann,M. Chisamore,U. Guha, H. Myint, D. Mahadevan
Annals of Oncology (2024): S575
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 39

#Citation: 143

H-Index: 6

G-Index: 11

Sociability: 6

Diversity: 1

Activity: 2

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn